Article Versions Notes

Wong SN, Weng J, Ip I, Chen R, Lakerveld R, Telford R, Blagden N, Scowen IJ, Chow SF. Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline. Pharmaceutics. 2022; 14(2):300. https://doi.org/10.3390/pharmaceutics14020300

Wong, Si Nga, Jingwen Weng, Ignatius Ip, Ruipeng Chen, Richard Lakerveld, Richard Telford, Nicholas Blagden, Ian J. Scowen, and Shing Fung Chow. 2022. "Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline" Pharmaceutics 14, no. 2: 300. https://doi.org/10.3390/pharmaceutics14020300

Wong, S. N., Weng, J., Ip, I., Chen, R., Lakerveld, R., Telford, R., Blagden, N., Scowen, I. J., & Chow, S. F. (2022). Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline. Pharmaceutics, 14(2), 300. https://doi.org/10.3390/pharmaceutics14020300